DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 40 filers reported holding DECIBEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,086,272 | +27.5% | 801,629 | 0.0% | 0.54% | +8.4% |
| Q1 2023 | $2,420,920 | +47.3% | 801,629 | 0.0% | 0.50% | +41.2% |
| Q4 2022 | $1,643,339 | -40.8% | 801,629 | 0.0% | 0.35% | -45.3% |
| Q3 2022 | $2,774,000 | -17.8% | 801,629 | 0.0% | 0.65% | -28.1% |
| Q2 2022 | $3,375,000 | +34.4% | 801,629 | -3.0% | 0.90% | +42.4% |
| Q1 2022 | $2,512,000 | -34.6% | 826,422 | 0.0% | 0.63% | -15.3% |
| Q4 2021 | $3,843,000 | -39.7% | 826,422 | 0.0% | 0.75% | -25.4% |
| Q3 2021 | $6,372,000 | -10.3% | 826,422 | 0.0% | 1.00% | +14.0% |
| Q2 2021 | $7,107,000 | -24.3% | 826,422 | 0.0% | 0.88% | -49.3% |
| Q1 2021 | $9,388,000 | – | 826,422 | – | 1.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,139,685 | $27,001,000 | 4.71% |
| Samsara BioCapital, LLC | 826,422 | $7,107,000 | 0.88% |
| Orbimed Advisors | 4,945,192 | $42,529,000 | 0.43% |
| Foresite Capital Management IV, LLC | 297,711 | $2,560,000 | 0.35% |
| Alphabet Inc. | 1,636,258 | $14,072,000 | 0.29% |
| Casdin Capital, LLC | 1,171,421 | $10,074,000 | 0.26% |
| HARVARD MANAGEMENT CO INC | 328,798 | $2,828,000 | 0.16% |
| Tibra Equities Europe Ltd | 43,400 | $373,000 | 0.12% |
| AlphaCentric Advisors LLC | 45,000 | $387,000 | 0.10% |
| Bronte Capital Management Pty Ltd. | 159,462 | $1,371,000 | 0.10% |